DOTA-CXCR4-L
Product Specifications
Target
CXCR
Related Pathways
Immunology/Inflammation, Autophagy, GPCR/G Protein
Bioactivity
DOTA-CXCR4-L, a peptide targeting the CXCR4 receptor, is utilized in cancer research, notably in the contexts of glioblastoma and triple-negative breast cancer [1].
Molecular Formula
C58H78N16O14
Molecular Weight
1223.34
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6037504 1.0 µg DNA
Traip sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details 
GTR15315544 1 Vial
Lentiviral human LBHD1 shRNA (UAS) - Lentiviral human LBHD1 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 221265-01 50 µL
Calnexin (Calnexin, IP90, Major histocompatibility Complex class I Antigen-Binding Protein p88, p90, CANX) discontinued
Sign In for Pricing
View Details 221265-02 100 µL
Calnexin (Calnexin, IP90, Major histocompatibility Complex class I Antigen-Binding Protein p88, p90, CANX) discontinued
Sign In for Pricing
View Details